Pharmacoregeneration for Chronic Spinal Cord Injury
Grant Project Details:
Isobel Scarisbrick, PhD
Mayo Clinic | Rochester, MN
Our goal is to develop a new treatment strategy that improves outcomes in individuals with chronic spinal cord injury. Studies will contribute to the identification of a drug target that increases neural connections in the brain and spinal cord capable of restoring function, long after the initial injury. We will also determine if this new approach can augment existing therapies to further enhance neural regeneration in the chronically injured adult brain and spinal cord.